SCHEMBL2431977

SCHEMBL2431977

CN(C)CCC(CCCN)Nc1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 6/20 0.54
▸ CSNK2B P67870 6/20 0.54
▸ CSNK2A1 P68400 6/20 0.54
▸ PIM1 P11309 14/20 0.52
▸ SGK1 O00141 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ GMNN O75496 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ CCNA2 P20248 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ THPO P40225 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ CCNA1 P78396 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2425919 0.87 PIM1 (0.59) CSNK2A2CSNK2BCSNK2A1PIM1
SCHEMBL1819537 0.71 CSNK2A2 (0.83) CSNK2A2CSNK2BCSNK2A1PIM1
SCHEMBL1759422 0.71 CSNK2A2 (1.00) CSNK2A2CSNK2BCSNK2A1PIM1
SCHEMBL1817935 0.69 PIM1 (0.65) CSNK2A2CSNK2BCSNK2A1PIM1SGK1
SCHEMBL1760566 0.68 CSNK2A1 (1.00) CSNK2A2CSNK2BCSNK2A1PIM1
SCHEMBL1814527 0.68 PIM1 (1.00) CSNK2A2CSNK2BCSNK2A1PIM1
SCHEMBL1816869 0.64 CSNK2A1 (0.53) CSNK2A2CSNK2BCSNK2A1PIM1SGK1
SCHEMBL1759675 0.63 CSNK2A1 (1.00) CSNK2A2CSNK2BCSNK2A1PIM1
SCHEMBL1813051 0.63 CSNK2A1 (0.51) CSNK2A2CSNK2BCSNK2A1PIM1SGK1
SCHEMBL10322725 0.61 PIM1 (0.81) CSNK2A2CSNK2BCSNK2A1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366695-A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent SELVITA S.A. (PL) 2011-09-21 — — EP claimed
Send feedback